Edwards Lifesciences Corp (NYSE:EW)

135.64
Delayed Data
As of Feb 23
 +1.97 / +1.47%
Today’s Change
89.20
Today|||52-Week Range
138.48
+20.34%
Year-to-Date
Recession is Coming! Not
Feb 23 / Zacks.com - Paid Partner Content
Edwards Lifesciences' CE Mark for CENTERA Boosts THVT Arm
Feb 16 / Zacks.com - Paid Partner Content
Here's Why You Should Invest in Edwards Lifesciences (EW) Now
Feb 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close133.67
Today’s open134.11
Day’s range133.01 - 135.69
Volume872,504
Average volume (3 months)1,511,354
Market cap$28.5B
Data as of 4:01pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+3.45%
Earnings growth (this year)+18.69%
Earnings growth (next 5 years)+17.50%
Revenue growth (last year)+15.91%
P/E ratio50.2
Price/Sales7.08
Price/Book9.62

Competitors

 Today’s
change
Today’s
% change
SNNSmith & Nephew PLC+0.50+1.40%
ISRGIntuitive Surgical+7.72+1.84%
STESTERIS plc+1.14+1.26%
HRCHill-Rom Holdings In...+0.62+0.74%
Data as of 4:02pm ET, 02/23/2018

Financials

Next reporting dateApril 25, 2018
EPS forecast (this quarter)$0.91
Annual revenue (last year)$3.4B
Annual profit (last year)$583.6M
Net profit margin16.99%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts